作者
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, C-Y Hsu, Y Shyr, X Li, TK Choueiri, CA Painter, S Peters, BI Rini, Michael A Thompson, S Mishra, DR Rivera, JD Acoba, MZ Abidi, Z Bakouny, B Bashir, T Bekaii-Saab, S Berg, EH Bernicker, MA Bilen, P Bindal, R Bishnoi, N Bouganim, DW Bowles, A Cabal, PF Caimi, DD Chism, J Crowell, C Curran, A Desai, B Dixon, DB Doroshow, EB Durbin, A Elkrief, D Farmakiotis, A Fazio, LA Fecher, DB Flora, CR Friese, J Fu, Shirish M Gadgeel, MD Galsky, DM Gill, MJ Glover, Sharad Goyal, P Grover, S Gulati, Shilpa Gupta, S Halabi, TR Halfdanarson, B Halmos, DJ Hausrath, JE Hawley, E Hsu, M Huynh-Le, Clara Hwang, C Jani, A Jayaraj, DB Johnson, A Kasi, H Khan, VS Koshkin, NM Kuderer, DH Kwon, PE Lammers, A Li, A Loaiza-Bonilla, CA Low, MB Lustberg, GH Lyman, RR McKay, C McNair, H Menon, RA Mesa, V Mico, D Mundt, G Nagaraj, ES Nakasone, J Nakayama, A Nizam, NL Nock, C Park, JM Patel, KG Patel, P Peddi, NA Pennell, AJ Piper-Vallillo, M Puc, D Ravindranathan, ME Reeves, DY Reuben, L Rosenstein, RP Rosovsky, SM Rubinstein, M Salazar, AL Schmidt, GK Schwartz, MR Shah, SA Shah, C Shah, JA Shaya, Sunny RK Singh, M Smits, KE Stockerl-Goldstein, DG Stover, M Streckfuss, S Subbiah, L Tachiki, E Tadesse, A Thakkar, MD Tucker, AK Verma, DC Vinh, M Weiss, JT Wu, E Wulff-Burchfield, Z Xie, PP Yu, T Zhang, AY Zhou, H Zhu, L Zubiri, DP Shah, JL Warner, GdL Lopes
发表日期
2021/6/1
期刊
Annals of oncology
卷号
32
期号
6
页码范围
787-800
出版商
Elsevier
简介
Background
Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19 and Cancer Consortium (CCC19) to identify prognostic clinical factors, including laboratory measurements and anticancer therapies.
Patients and methods
Patients with active or historical cancer and a laboratory-confirmed SARS-CoV-2 diagnosis recorded between 17 March and 18 November 2020 were included. The primary outcome was COVID-19 severity measured on an ordinal scale (uncomplicated, hospitalized, admitted to intensive care unit, mechanically ventilated, died within 30 days). Multivariable regression models included demographics, cancer status, anticancer therapy and timing, COVID-19-directed therapies, and laboratory measurements …
学术搜索中的文章
P Grivas, AR Khaki, TM Wise-Draper, B French… - Annals of oncology, 2021